rs398123335

Variant summary

Our verdict is Benign. The variant received -15 ACMG points: 1P and 16B. PM4_SupportingBP6_Very_StrongBS1BS2

The NM_001034853.2(RPGR):​c.1579_1581delCAA​(p.Gln527del) variant causes a conservative inframe deletion change. The variant allele was found at a frequency of 0.0228 in 1,206,736 control chromosomes in the GnomAD database, including 280 homozygotes. There are 8,407 hemizygotes in GnomAD. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.020 ( 38 hom., 594 hem., cov: 21)
Exomes 𝑓: 0.023 ( 242 hom. 7813 hem. )

Consequence

RPGR
NM_001034853.2 conservative_inframe_deletion

Scores

Not classified

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8O:1

Conservation

PhyloP100: 5.33

Publications

1 publications found
Variant links:
Genes affected
RPGR (HGNC:10295): (retinitis pigmentosa GTPase regulator) This gene encodes a protein with a series of six RCC1-like domains (RLDs), characteristic of the highly conserved guanine nucleotide exchange factors. The encoded protein is found in the Golgi body and interacts with RPGRIP1. This protein localizes to the outer segment of rod photoreceptors and is essential for their viability. Mutations in this gene have been associated with X-linked retinitis pigmentosa (XLRP). Multiple alternatively spliced transcript variants that encode different isoforms of this gene have been reported, but the full-length natures of only some have been determined. [provided by RefSeq, Dec 2008]
RPGR Gene-Disease associations (from GenCC):
  • retinitis pigmentosa 3
    Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • RPGR-related retinopathy
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • primary ciliary dyskinesia-retinitis pigmentosa syndrome
    Inheritance: XL Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
  • cone-rod dystrophy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • retinitis pigmentosa
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • macular degeneration, X-linked atrophic
    Inheritance: XL Classification: LIMITED Submitted by: G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -15 ACMG points.

PM4
Nonframeshift variant in NON repetitive region in NM_001034853.2. Strenght limited to Supporting due to length of the change: 1aa.
BP6
Variant X-38288032-TTTG-T is Benign according to our data. Variant chrX-38288032-TTTG-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 92853.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0196 (2195/112164) while in subpopulation NFE AF = 0.0288 (1531/53245). AF 95% confidence interval is 0.0276. There are 38 homozygotes in GnomAd4. There are 594 alleles in the male GnomAd4 subpopulation. Median coverage is 21. This position passed quality control check.
BS2
High AC in GnomAd4 at 2195 XL,AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RPGRNM_001034853.2 linkc.1579_1581delCAA p.Gln527del conservative_inframe_deletion Exon 14 of 15 ENST00000645032.1 NP_001030025.1 Q92834-6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RPGRENST00000645032.1 linkc.1579_1581delCAA p.Gln527del conservative_inframe_deletion Exon 14 of 15 NM_001034853.2 ENSP00000495537.1 Q92834-6
ENSG00000250349ENST00000465127.1 linkc.172-378083_172-378081delGTT intron_variant Intron 3 of 8 5 ENSP00000417050.1 B4E171

Frequencies

GnomAD3 genomes
AF:
0.0196
AC:
2195
AN:
112113
Hom.:
38
Cov.:
21
show subpopulations
Gnomad AFR
AF:
0.00347
Gnomad AMI
AF:
0.197
Gnomad AMR
AF:
0.0158
Gnomad ASJ
AF:
0.0427
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000738
Gnomad FIN
AF:
0.0186
Gnomad MID
AF:
0.0417
Gnomad NFE
AF:
0.0287
Gnomad OTH
AF:
0.0153
GnomAD2 exomes
AF:
0.0183
AC:
3341
AN:
182433
AF XY:
0.0169
show subpopulations
Gnomad AFR exome
AF:
0.00396
Gnomad AMR exome
AF:
0.0125
Gnomad ASJ exome
AF:
0.0439
Gnomad EAS exome
AF:
0.0000722
Gnomad FIN exome
AF:
0.0183
Gnomad NFE exome
AF:
0.0263
Gnomad OTH exome
AF:
0.0287
GnomAD4 exome
AF:
0.0232
AC:
25343
AN:
1094572
Hom.:
242
AF XY:
0.0216
AC XY:
7813
AN XY:
361364
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00379
AC:
100
AN:
26364
American (AMR)
AF:
0.0131
AC:
461
AN:
35184
Ashkenazi Jewish (ASJ)
AF:
0.0407
AC:
788
AN:
19342
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30192
South Asian (SAS)
AF:
0.00338
AC:
183
AN:
54091
European-Finnish (FIN)
AF:
0.0210
AC:
846
AN:
40372
Middle Eastern (MID)
AF:
0.0389
AC:
160
AN:
4109
European-Non Finnish (NFE)
AF:
0.0260
AC:
21777
AN:
838924
Other (OTH)
AF:
0.0224
AC:
1028
AN:
45994
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.389
Heterozygous variant carriers
0
773
1545
2318
3090
3863
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
792
1584
2376
3168
3960
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0196
AC:
2195
AN:
112164
Hom.:
38
Cov.:
21
AF XY:
0.0173
AC XY:
594
AN XY:
34328
show subpopulations
African (AFR)
AF:
0.00346
AC:
107
AN:
30946
American (AMR)
AF:
0.0157
AC:
166
AN:
10552
Ashkenazi Jewish (ASJ)
AF:
0.0427
AC:
113
AN:
2646
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3606
South Asian (SAS)
AF:
0.000740
AC:
2
AN:
2702
European-Finnish (FIN)
AF:
0.0186
AC:
113
AN:
6059
Middle Eastern (MID)
AF:
0.0411
AC:
9
AN:
219
European-Non Finnish (NFE)
AF:
0.0288
AC:
1531
AN:
53245
Other (OTH)
AF:
0.0151
AC:
23
AN:
1524
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
83
165
248
330
413
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
24
48
72
96
120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0280
Hom.:
226
Bravo
AF:
0.0190
Asia WGS
AF:
0.00438
AC:
11
AN:
2522
EpiCase
AF:
0.0281
EpiControl
AF:
0.0276

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:8Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
Jan 13, 2024
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: RPGR c.1579_1581delCAA (p.Gln527del) results in an in-frame deletion that is predicted to remove 1 amino acid from the encoded protein. The variant allele was found at a frequency of 0.018 in 182433 control chromosomes, predominantly at a frequency of 0.026 within the Non-Finnish European subpopulation in the gnomAD database, including 16 homozygotes. The observed variant frequency within Non-Finnish European control individuals in the gnomAD database is approximately 5.2 fold of the estimated maximal expected allele frequency for a pathogenic variant in RPGR causing Retinitis Pigmentosa, X-Linked phenotype (0.005), strongly suggesting that the variant is a benign polymorphism found primarily in populations of Non-Finnish European origin. c.1579_1581delCAA has been reported in the literature studying genetic susceptibility of Pulmonary Nontuberculous Mycobacterial Infectioin, without further information for analysis (Szymanski_2015). These report(s) do not provide unequivocal conclusions about association of the variant with Retinitis Pigmentosa, X-Linked. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication have been ascertained in the context of this evaluation (PMID: 26038974). ClinVar contains an entry for this variant (Variation ID: 92853. Benign/Likely Benign). Based on the evidence outlined above, the variant was classified as benign. -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 03, 2013
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 29, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

p.Gln527del in exon 14 of RPGR: This variant is not expected to have clinical si gnificance because it has been identified in 2.8% (1333/46868) of European chrom osomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org ; dbSNP rs398123335). -

not provided Benign:2Other:1
-
Retina International
Significance:not provided
Review Status:no classification provided
Collection Method:literature only

- -

Oct 23, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 18, 2019
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 26038974) -

Primary ciliary dyskinesia Benign:2
Dec 26, 2014
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
5.3
Mutation Taster
=82/18
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs62653033; hg19: chrX-38147285; COSMIC: COSV58835696; API